Insider Selling: Dolby Laboratories major shareholder Sells 80,000 Shares of Stock (DLB)
Dolby Laboratories (NYSE:DLB) major shareholder Dagmar Dolby sold 80,000 shares of the stock on the open market in a transaction dated Friday, August 22nd. The stock was sold at an average price of $46.47, for a total transaction of $3,717,600.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Dolby Laboratories (NYSE:DLB) traded up 0.54% on Monday, hitting $46.84. The stock had a trading volume of 271,089 shares. Dolby Laboratories has a 1-year low of $31.19 and a 1-year high of $46.95. The stock’s 50-day moving average is $44.40 and its 200-day moving average is $42.74. The company has a market cap of $4.784 billion and a P/E ratio of 23.28.
Dolby Laboratories (NYSE:DLB) last announced its earnings results on Thursday, July 24th. The company reported $0.38 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.27 by $0.11. The company had revenue of $223.40 million for the quarter, compared to the consensus estimate of $210.23 million. During the same quarter last year, the company posted $0.47 earnings per share. Dolby Laboratories’s revenue was up 7.9% compared to the same quarter last year. On average, analysts predict that Dolby Laboratories will post $1.86 earnings per share for the current fiscal year.
A number of analysts have recently weighed in on DLB shares. Analysts at Zacks downgraded shares of Dolby Laboratories from an “outperform” rating to a “neutral” rating in a research note on Wednesday, July 30th. They now have a $48.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “underweight” rating on shares of Dolby Laboratories in a research note on Friday, July 25th. They now have a $43.00 price target on the stock, up previously from $38.00. Finally, analysts at B. Riley initiated coverage on shares of Dolby Laboratories in a research note on Tuesday, July 1st. They set a “neutral” rating and a $41.00 price target on the stock.
Dolby Laboratories, Inc designs and manufactures video and audio products for the film production, cinema, and television broadcast industries.
Receive News & Ratings for Dolby Laboratories Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.